{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:50:14Z","timestamp":1774353014165,"version":"3.50.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN 261201700012I\/75N91020F00001)"],"award-info":[{"award-number":["HHSN 261201700012I\/75N91020F00001)"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science, Innovation, Technology and Telecomunications Ministry of Costa Rica","award":["FI-005-20"],"award-info":[{"award-number":["FI-005-20"]}]},{"name":"Costa Rican Biomedical Research Agency-Fundacion INCIENSA","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Previous SARS-CoV-2 research indicates that antibody levels and corresponding neutralization potential increase with additional exposures (comprising vaccination or infection), and that hybrid immunity resulting from combined vaccination and natural infection is more robust than either alone. However, it is unclear whether or how antibody levels increase or eventually plateau with repeated exposures and how SARS-CoV-2 exposure differs by sex or other demographic factors. Research regarding the association of antibody production with neutralization potential is also limited. We conducted this analysis within the RESPIRA population-based cohort in Costa Rica to investigate relationships between antibody levels and neutralization potential at increasing exposure levels. We examined immunological profiles from systematically defined single-exposure groups (one vaccine dose or one natural infection), double-exposure groups (two vaccine doses or one vaccine dose following a natural infection), and a triple-exposure group (two vaccine doses following a natural infection). We used a S1-RBD-based serological assay for antibody level detection and a pseudovirion assay for neutralization potential quantification. Using linear regression, we compared antibody levels and pseudoneutralization geometric mean titers between exposure groups. For single exposure groups, one vaccine dose was inferior to natural infection, but a second vaccine dose was superior to natural infection. For double exposure groups, those who were vaccinated once after infection developed higher levels of antibodies and higher neutralization potential compared with those who had only two vaccine doses. We note that peak antibody levels following an exposure may plateau after two exposures while neutralization potential continues to increase with a third exposure dose. Response patterns were comparable in males and females and in sensitivity analyses stratified by age, vaccine type, and pandemic wave. These results provide evidence that SARS-CoV-2 vaccination after COVID infection provides immunological benefit and suggest neutralization potential continues to increase after a second vaccine dose despite plateauing of antibody levels.<\/jats:p>","DOI":"10.1371\/journal.pone.0331212","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T17:27:37Z","timestamp":1756920457000},"page":"e0331212","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9915-9091","authenticated-orcid":true,"given":"Christopher S.","family":"Semancik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Fantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Abdelnour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Loria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Porras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amada","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Wong-McClure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-5142","authenticated-orcid":true,"given":"Rebeca","family":"Ocampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin","family":"Morera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Z\u00fa\u00f1iga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernal","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Rebecca","family":"Prevots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0257-2363","authenticated-orcid":true,"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the RESPIRA Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"issue":"10334","key":"pone.0331212.ref001","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","author":"Collaborators C-EM","year":"2022","journal-title":"Lancet"},{"key":"pone.0331212.ref002","doi-asserted-by":"crossref","first-page":"741796","DOI":"10.3389\/fimmu.2021.741796","article-title":"Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults","volume":"12","author":"MR Petrara","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"pone.0331212.ref003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.21616","article-title":"Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection","volume":"5","author":"C Di Chiara","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6511","key":"pone.0331212.ref004","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Y Cai","year":"2020","journal-title":"Science"},{"issue":"2","key":"pone.0331212.ref005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jgg.2021.02.006","article-title":"COVID-19 mRNA vaccines","volume":"48","author":"Q Huang","year":"2021","journal-title":"J Genet Genomics"},{"issue":"1","key":"pone.0331212.ref006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s41182-020-00285-w","article-title":"Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review","volume":"48","author":"T Girum","year":"2020","journal-title":"Trop Med Health"},{"key":"pone.0331212.ref007","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80428","article-title":"Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies","volume":"12","author":"NJ Cheetham","year":"2023","journal-title":"Elife"},{"key":"pone.0331212.ref008","doi-asserted-by":"crossref","first-page":"1230974","DOI":"10.3389\/fimmu.2023.1230974","article-title":"Natural infection versus hybrid (natural and vaccination) humoral immune response to SARS-CoV-2: a comparative paired analysis","volume":"14","author":"L AbdelWareth","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0331212.ref009","doi-asserted-by":"crossref","first-page":"2273155","DOI":"10.1080\/21645515.2023.2273155","article-title":"Comparing the immune response and protective effect of COVID-19 vaccine under different vaccination strategies","volume":"19","author":"T Zhao","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"pone.0331212.ref010","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jiph.2023.05.018","article-title":"Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infection","volume":"16","author":"M Franchi","year":"2023","journal-title":"J Infect Public Health"},{"issue":"3","key":"pone.0331212.ref011","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-022-01715-4","article-title":"Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern","volume":"28","author":"PR Wratil","year":"2022","journal-title":"Nature Medicine"},{"issue":"7","key":"pone.0331212.ref012","article-title":"How humoral response and side effects depend on the type of vaccine and past SARS-CoV-2 infection","volume":"10","author":"M Stepien","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"pone.0331212.ref013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/vaccines11010149","article-title":"Immune Response to Vaccination against COVID-19 at Different Second-Dose Intervals and Their Associations with Metabolic Parameters","volume":"11","author":"\u0141 Szczerbi\u0144ski","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"pone.0331212.ref014","doi-asserted-by":"crossref","first-page":"115803","DOI":"10.1016\/j.diagmicrobio.2022.115803","article-title":"SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays","volume":"104","author":"J Meyers","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"pone.0331212.ref015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45718-8","article-title":"Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein","volume":"13","author":"G den Hartog","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0331212.ref016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s43856-023-00303-y","article-title":"Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation","volume":"3","author":"SJC Pallett","year":"2023","journal-title":"Commun Med (Lond)"},{"issue":"5","key":"pone.0331212.ref017","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10050967","article-title":"Evaluation of S1RBD-Specific IgG Antibody Responses Following COVID-19 Vaccination in Healthcare Professionals in Cyprus: A Comparative Look Between the Vaccines of Pfizer-BioNTech and AstraZeneca","volume":"10","author":"E Deeba","year":"2022","journal-title":"Microorganisms"},{"issue":"1","key":"pone.0331212.ref018","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12916-022-02547-2","article-title":"SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia","volume":"20","author":"M Karachaliou","year":"2022","journal-title":"BMC Med"},{"issue":"1","key":"pone.0331212.ref019","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41467-022-28527-x","article-title":"Population antibody responses following COVID-19 vaccination in 212,102 individuals","volume":"13","author":"H Ward","year":"2022","journal-title":"Nature Communications"},{"issue":"11","key":"pone.0331212.ref020","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3390\/v15112250","article-title":"Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study","volume":"15","author":"C Zirou","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"pone.0331212.ref021","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/vaccines11020442","article-title":"Analysis of Antibodies Induced after SARS-CoV-2 Vaccination Using Antigen Coded Bead Array Luminex Technology","volume":"11","author":"Z Song","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"68","key":"pone.0331212.ref022","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8014","article-title":"Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants","volume":"7","author":"TA Bates","year":"2022","journal-title":"Sci Immunol"},{"issue":"1","key":"pone.0331212.ref023","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1038\/s41467-023-40195-z","article-title":"Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology","volume":"14","author":"B de Gier","year":"2023","journal-title":"Nat Commun"},{"key":"pone.0331212.ref024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijid.2023.08.009","article-title":"Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022","volume":"135","author":"M Edelstein","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"3","key":"pone.0331212.ref025","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"K Srivastava","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"pone.0331212.ref026","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/vaccines12020199","article-title":"Immune Response to COVID-19 Vaccination in Frontline Healthcare Workers","volume":"12","author":"B Strukcinskiene","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"pone.0331212.ref027","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s42003-021-01649-6","article-title":"SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus","volume":"4","author":"M Dogan","year":"2021","journal-title":"Commun Biol"},{"issue":"12","key":"pone.0331212.ref028","article-title":"Overview of Neutralizing Antibodies and Their Potential in COVID-19","volume":"9","author":"JJ Morales-Nunez","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"pone.0331212.ref029","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"SL Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"pone.0331212.ref030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12879-025-10742-8","article-title":"Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study","volume":"25","author":"R Herrero","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"12","key":"pone.0331212.ref031","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071284","article-title":"Cohort profile: evaluation of immune response and household transmission of SARS-CoV-2 in Costa Rica: the RESPIRA study","volume":"13","author":"V Loria","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0331212.ref032","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1186\/s12879-022-07740-5","article-title":"Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica","volume":"22","author":"R Fantin","year":"2022","journal-title":"BMC Infect Dis"},{"key":"pone.0331212.ref033","first-page":"100616","article-title":"Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohort","volume":"27","author":"R Fantin","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"pone.0331212.ref034","doi-asserted-by":"crossref","unstructured":"Ochoa Chaves L, Oscar Mario Jim\u00e9nez A, y Fernando Mart\u00ednez de L. Expediente digital \u00fanico en salud (EDUS) de Costa Rica: buenas pr\u00e1cticas, historia e implementaci\u00f3n 2023. https:\/\/doi.org\/10.18235\/0005019","DOI":"10.18235\/0005019"},{"issue":"5","key":"pone.0331212.ref035","doi-asserted-by":"crossref","DOI":"10.3390\/v13050749","article-title":"From multiplex serology to serolomics-a novel approach to the antibody response against the SARS-CoV-2 proteome","volume":"13","author":"J Butt","year":"2021","journal-title":"Viruses"},{"issue":"42","key":"pone.0331212.ref036","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.42.2000685","article-title":"Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020","volume":"25","author":"CP Thompson","year":"2020","journal-title":"Euro Surveill"},{"issue":"7","key":"pone.0331212.ref037","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jiab593","article-title":"Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 vaccines","volume":"225","author":"V Naranbhai","year":"2022","journal-title":"J Infect Dis"},{"issue":"6","key":"pone.0331212.ref038","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17410","article-title":"Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects","volume":"9","author":"L Dulipsingh","year":"2023","journal-title":"Heliyon"},{"issue":"12","key":"pone.0331212.ref039","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.vaccine.2022.02.002","article-title":"Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study","volume":"40","author":"P Stefanizzi","year":"2022","journal-title":"Vaccine"},{"issue":"14","key":"pone.0331212.ref040","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine","volume":"384","author":"F Krammer","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0331212.ref041","doi-asserted-by":"crossref","first-page":"114684","DOI":"10.1016\/j.celrep.2024.114684","article-title":"SARS-CoV-2 infection prior to vaccination amplifies Fc-mediated humoral profiles in an age-dependent manner","volume":"43","author":"W Jung","year":"2024","journal-title":"Cell Rep"},{"key":"pone.0331212.ref042","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coviro.2015.04.002","article-title":"Strategies to guide the antibody affinity maturation process","volume":"11","author":"NA Doria-Rose","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"8","key":"pone.0331212.ref043","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113512119","article-title":"Affinity maturation for an optimal balance between long-term immune coverage and short-term resource constraints","volume":"119","author":"V Chardes","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pone.0331212.ref044","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/imm.13464","article-title":"NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion-the differences and similarities","volume":"166","author":"K Roe","year":"2022","journal-title":"Immunology"},{"issue":"6","key":"pone.0331212.ref045","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/all.15652","article-title":"Sex-specific differences in immune response to SARS-CoV-2 vaccination vanish with age","volume":"78","author":"D Brigger","year":"2023","journal-title":"Allergy"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0331212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T17:27:44Z","timestamp":1756920464000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0331212"}},"subtitle":[],"editor":[{"given":"Roland","family":"Zahn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0331212","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}